Make your money go further for just 25p per day

Science in Sport (SIS)

Market: AIM · Sector: Food & Drug Retailers

Company Insights

Blue Prism tumbles but others impress

14/01/2021
A much-hyped business leaves plenty of questions unanswered

More on Science in Sport


AIM IHT
Company Insights

Big investment potential from neuroscience

02/12/2020
PREMIUM
Company Insights

Is Science in Sport good value at last? (Updated)

02/12/2020
Company Insights

Vaccine countdown update: 19 Nov - some awful results here, but promise nonetheless

19/11/2020
AIM IHT
Company Insights

Coronavirus impact: 16 Sept - keep an eagle eye on this

16/09/2020
Company Insights

Coronavirus impact: 9 July - another fuel cell group powers past £1billion

09/07/2020
Company Insights

Coronavirus impact: 25 June - cycling is having a great lockdown as this company demonstrates

25/06/2020
Company Insights

Coronavirus impact: 23 April - wonderful timing leaves this business awash with cash

23/04/2020
Company Insights

Stock Market hype: perfectly illustrated by Science in Sport

16/11/2018
Company Insights

Science in Sport – fit for purpose?

21/09/2018
Company Insights

Science in Sport (AIM:SIS) – will the sports nutrition company deliver for shareholders?

03/10/2017
Company Insights

Science in Sport (AIM:SIS) - self-funding profitable growth looks less likely

07/07/2017
Company Insights

Our Premium Company Research offers have kicked-off rather well!

24/02/2017
Company Insights

Science in Sport (AIM: SIS) - Positive financial results from this exciting sports nutrition company

26/03/2015
Company Insights

Science in Sport (AIM: SIS) – expanding market and an expanding brand

13/02/2015